Statistical fundamentals on cancer research for clinicians: Working with your statisticians

Abstract

To facilitate understanding statistical principles and methods for clinicians involved in cancer research. Methods: An overview of study design is provided on cancer research for both observational and clinical trials addressing study objectives and endpoints, superiority tests, non-inferiority and equivalence design, and sample size calculation. The principles of statistical models and tests including contemporary standard methods of analysis and evaluation are discussed. Finally, some statistical pitfalls frequently evident in clinical and translational studies in cancer are discussed. Results: We emphasize the practical aspects of study design (superiority vs non-inferiority vs equivalence study) and assumptions underpinning power calculations and sample size estimation. The differences between relative risk, odds ratio, and hazard ratio, understanding outcome endpoints, purposes of interim analysis, and statistical modeling to minimize confounding effects and bias are also discussed. Conclusion: Proper design and correctly constructed statistical models are critical for the success of cancer research studies. Most statistical inaccuracies can be minimized by following essential statistical principles and guidelines to improve quality in research studies.

The Clinicopathological Characteristics of Young-Onset Versus Adult-Onset Colorectal Cancer: A Tertiary Hospital-Based Study

“…The study was restricted to a small sample size, which may not represent the total population of Kelantan ( 28 ). In addition, the limited sample size in this study reduced the statistical power, possibly influencing the significance of the findings ( 47 ). The study only included one tertiary health institution, making it susceptible to a referral bias ( 48 ).…”

Nomogram-based prognostic tool for stage IIIB/IV non-small cell lung cancer patients undergoing traditional Chinese medicine treatment

“…The calibration curve method assessed predictive accuracy by comparing the projected survival time derived from the nomograms with the actual survival time of the patient. The DCA was used to predict the clinical usefulness and benefits of the nomograms, based on their clinical accuracy, practicability, and effectiveness, and the bootstrap method was used for resampling, with the number of repetitions set to 1000 for internal validation [ [16] , [17] , [18] ].…”

Unleashing the Power of OpenAI in Shaping the Future of Cancer Research

“…A major goal in cancer research is to improve the efficiency and accuracy of data analysis 67,68 . AI is playing an important role in this area by automating the analysis of large amounts of data, reducing the time and effort required to identify patterns and correlations 68,69 .…”